Methods
=======

The nuclear factor-kappaB (NF-κB) family of transcription factors regulates the expression of hundreds of genes including pro-inflammatory and apoptosis genes \[[@B1]-[@B3]\]. Transcription of these genes is activated by five NF-κB subunits (*NFKB1*encoding p50, *NFKB2*encoding p52, *REL*encoding c-Rel, *RELA*encoding p65, and *RELB*encoding Rel-B). The NF-κB pathway is a critical candidate gene pathway for numerous cancers and cardiovascular endpoints.

Samples and data availability
-----------------------------

Genetic Analysis Workshop 15 (GAW15) Problem 1 included data on 14 three-generation pedigrees (two sets of grandparents, one set of parents, and a sibship of eight individuals) consisting of Utah residents with ancestry from northern and western Europe (CEPH-Utah, CEU). Pedigree members had genotypes on \~2882 single-nucleotide polymorphisms (SNPs) spread throughout the genome and \~3554 phenotypes consisting of expression levels from lymphoblastoid cells hybridized onto Affymetrix Genome Focus Arrays \[[@B4]\]. Expression density was scaled to 500 and transformed by log~2~\[[@B4]\]. Forty-two participants (14 trios) were also studied by the International HapMap Consortium; thus, additional genotype data were available on selected individuals (including 28 unrelated individuals) in families 1340, 1341, 1345, 1346, 1347, 1362, 1408, 1416, and 1454 \[[@B5],[@B6]\].

Genotype selection
------------------

Genotypes from 21 GAW15-provided SNPs surrounding \~20 cM of each candidate gene were analyzed: *NFKB1*(90.6 cM to 117.5 cM on chromosome 4), *NFKB2*(94.5 cM to 119.8 cM on chromosome 10), *REL*(45.7 cM to 73.4 cM on chromosome 2), *RELA*(44.7 cM to 78.4 cM on chromosome 11), and *RELB*(41.2 cM to 58.0 cM on chromosome 19). Denser genotypes from HapMap within 5 kb of each gene were also used: *NFKB1*(106 SNPs, mean *r*^2^= 0.25), *NFKB2*(3 SNPs, mean *r*^2^= 0.01), *REL*(16 SNPs, mean *r*^2^= 0.41), *RELA*(3 SNPs, mean *r*^2^= 0.07), and *RELB*(8 SNPs, mean *r*^2^= 0.18).

Phenotype selection and heritability
------------------------------------

Regulatory targets of NF-κB transcription (*N*= 165) were compiled from review of the literature \[[@B1]-[@B3]\] and online catalogs \[[@B7]\]. Expression levels of 75 from these target genes were available in the GAW15 Problem 1 data. We estimated heritability (*h*^2^) using the Splus/R library *multic*\[[@B9]\] assuming a polygenic model in the 14 pedigrees. Fifteen phenotypes with *h*^2^greater than 0.4 (*p*-value \< 0.001) were included in the current analysis (Table [1](#T1){ref-type="table"}). Additional *h*^2^estimates are available upon request.

###### 

Heritability (*h*^2^), association testing (minimum *p*-values of SNP and haplotype association test), and linkage analysis (maximum LOD scores)^a^

                                          *NFKB1*(106 SNPs)   *NFKB2*(3 SNPs)   *REL*(16 SNPs)   *RELA*(3 SNPs)                                                                             
  -------- -------------- ------ -------- ------------------- ----------------- ---------------- ---------------- -------- ---------- ------------ ----------- ---------- -------- -------- ----------
  BCL2A1   205681_at      0.42   0.0008   **0.029**           **0.040**         \<1.00           **0.04**         \>0.05   \<1.00     \>0.05       \>0.05      **1.70**   \>0.05   \>0.05   **1.61**
  BIRC2    202076_at      0.48   0.0003   \>0.05              \>0.05            \<1.00           \>0.05           \>0.05   \<1.00     \>0.05       \>0.05      \<1.00     \>0.05   \>0.05   **1.24**
  CD40     35150_at       0.49   0.0003   \>0.05              \>0.05            \<1.00           **0.01**         \>0.05   \<1.00     **0.28**     **0.047**   **2.17**   \>0.05   \>0.05   **1.31**
  CD44     204490_s\_at   0.46   0.0004   **0.034**           **0.009**         \<1.00           \>0.05           \>0.05   \<1.00     \>0.05       \>0.05      \<1.00     \>0.05   \>0.05   \<1.00
  CD80     207176_s\_at   0.49   0.0003   **0.025**           **0.017**         \<1.00           \>0.05           \>0.05   \<1.00     \>0.05       \>0.05      \<1.00     \>0.05   \>0.05   \<1.00
  CFLAR    211317_s\_at   0.48   0.0003   \>0.05              \>0.05            \<1.00           **0.05**         \>0.05   \<1.00     \>0.05       \>0.05      \<1.00     \>0.05   \>0.05   \<1.00
  CR2      205544_s\_at   0.47   0.0003   \>0.05              \>0.05            \<1.00           **0.02**         \>0.05   \<1.00     \>0.05       \>0.05      \<1.00     \>0.05   \>0.05   \<1.00
  FAS      204780_s\_at   0.43   0.0007   **0.032**           \>0.05            **1.38**         \>0.05           \>0.05   \<1.00     \>0.05       \>0.05      \<1.00     \>0.05   \>0.05   \<1.00
  ICAM1    202638_s\_at   0.46   0.0004   **0.025**           **0.05**          \<1.00           **0.05**         \>0.05   \<1.00     \>0.05       \>0.05      \<1.00     \>0.05   \>0.05   \<1.00
  IL15     205992_s\_at   0.41   0.0009   **0.013**           \>0.05            \<1.00           \>0.05           \>0.05   \<1.00     **0.038**    **0.05**    \<1.00     \>0.05   \>0.05   \<1.00
  IRF1     202531_at      0.42   0.0009   **0.031**           **0.022**         **2.54**         \>0.05           \>0.05   **1.45**   **0.01**     **0.05**    \<1.00     \>0.05   \>0.05   \<1.00
  JUNB     201473_at      0.41   0.0009   **0.033**           \>0.05            \<1.00           **0.01**         \>0.05   \<1.00     **0.0082**   **0.016**   \<1.00     \>0.05   \>0.05   \<1.00
  MYC      202431_s\_at   0.51   0.0002   \>0.05              \>0.05            \<1.00           \>0.05           \>0.05   \<1.00     \>0.05       \>0.05      **1.37**   \>0.05   \>0.05   \<1.00
  SLC2A5   204429_s\_at   0.47   0.0003   \>0.05              \>0.05            \<1.00           **0.03**         \>0.05   **1.01**   **0.02**     **0.002**   \<1.00     \>0.05   \>0.05   \<1.00
  VCAM1    203886_s\_at   0.43   0.0007   **0.011**           **0.010**         \<1.00           \>0.05           \>0.05   \<1.00     **0.01**     **0.048**   \<1.00     \>0.05   \>0.05   \<1.00

^a^No suggestive results were found for *RELB*genotypes (8 SNPs) and any phenotype. HapMap data was used for association testing; GAW15 data was used for linkage analysis.

^b^Bold indicates *p*-values of SNP or haplotype association test ≤0.05 or LOD score of linkage analysis \>1.

Linkage analysis in extended pedigrees
--------------------------------------

Variance components multipoint linkage analysis of 15 expression levels was performed using *multic*\[[@B9]\] with GAW15 genotype data among 14 extended pedigrees (194 individuals), assuming 1 Mb\~1 cM.

Family-based association
------------------------

Family-based association tests (single-SNP and three-SNP haplotypes) were performed using the program *FBAT*\[[@B10]\] to examine the null hypothesis of no association and no linkage. Two analyses were conducted for each phenotype; first, dense HapMap genotypes in 14 trios, and second, GAW15 genotypes in 14 extended pedigrees.

Association in unrelated individuals
------------------------------------

Using data on 28 unrelated individuals, analysis of variance (ANOVA) tested associations between 15 heritable expression levels and genotypes at dense HapMap SNPs surrounding the five candidate genes. With the Splus library *HaploStat*\[[@B8]\], score testing assessed haplotype associations.

Results
=======

Linkage analysis
----------------

Linkage analysis showed elevated LOD scores in the *NFKB1*(FAS and IRF1 expression), *NFKB2*(IRF1 and SLC2A5 expression), *REL*(CD40, BCL2A1, and MYC expression), and *RELA*regions (CD40, BCL2A1, and BIRC2 expression). Linkage regions and maximum LOD scores for each gene are presented in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}.

###### 

Linkage analysis and family-based association tests (FBAT) using GAW15 data

                           Linkage analysis   FBAT (*p*\< 0.05)               
  ------------------------ ------------------ ------------------- ----------- -------------------------------
  *NFKB1*(chromosome 4)                                                       
   FAS                     1.38 (101.0)       97.4--106.8         rs721412    rs765220-rs971696-rs721412
   IRF1                    2.54 (106.7)       94.0--109.0                     rs971696-rs721412-rs1557803
                                                                              
  *NFKB2*(chromosome 10)                                                      
   IRF1                    1.45 (102.1)       100.0--112.0        \-\--       \-\--
   SLC2A5                  1.01 (97.5)        97.5--98.2                      
                                                                              
  *REL*(chromosome 2)                                                         
   CD40                    2.17 (70.2)        62.4--73.7          rs1363062   rs1520446-rs1974771-rs1363062
   BCL2A1                  1.70 (70.2)        67.0--73.7          rs1106577   rs1177274-rs2167564-rs1106577
   MYC                     1.37 (47.7)        45.0--50.0                      rs2167564-rs1106577-rs2216924
                                                                              
  *RELA*(chromosome 4)                                                        
   CD40                    1.31 (60.6)        60.6--62.4          rs1867791   rs1966864-rs1993205-rs1867791
   BCL2A1                  1.61 (60.8)        60.6--65.1                      rs1867791-rs999297-rs175110
   BIRC2                   1.24 (61.0)        60.6--63.8                      
                                                                              
  *RELB*(chromosome 19)                                                       
   FAS                     0.66 (58.0)        \-\--               \-\--       \-\--

^a^For each gene, SNPs and haplotypes were the same for all the phenotypes shown.

Family-based association tests (FBAT)
-------------------------------------

Analyses using GAW15-provided genotypes surrounding *NFKB1*suggested an association between rs721412 at 111.3 cM and FAS, IRF1 expression. Haplotypes containing this SNP were also associated with FAS and IRF1 expression (Table [2](#T2){ref-type="table"}). Using the HapMap data we found rs4648134 at 103.9 cM associated with CD80, FAS and ICAM1 phenotypes across three different methods (association, linkage, and FBAT) (Table [3](#T3){ref-type="table"}). Analysis of *REL*GAW15 data revealed associations between genotypes at rs1363062 and rs1106577 and CD40, BCL2A1, and MYC expression levels (Table [2](#T2){ref-type="table"}). FBAT analysis of denser *REL*HapMap data did not suggest any association with SNPs or haplotypes and any phenotype (Table [4](#T4){ref-type="table"}). Using GAW15 data in the *RELA*region, we found that genotypes of rs1867791 at 44.9 cM had FBAT *p*-values of 0.02. Haplotype FBAT analysis indicated that two haplotypes were point-wise significantly associated with CD40, BCL2A1, and BIRC2 expression (Table [2](#T2){ref-type="table"}). Using HapMap data, genotypes at rs11820062 were associated with each phenotype (*p*-values\~0.02), and haplotype rs2306365-rs732072-rs11820062 was associated with all phenotypes (*p*-values\~0.03).

###### 

Association analysis of *NFKB1*using HapMap data^a^

  Phenotype   SNP          *p*-Value   Haplotype                        *p*-Value
  ----------- ------------ ----------- -------------------------------- -----------
  BCL2A1      rs17032779   0.035       rs17032779-rs230519-rs93059      0.040
                                                                        
  CD44        rs230506     0.034       rs230506-rs230505-rs230504       0.009
              rs3774934    0.034       rs3774933-rs3774934-rs4647972    0.037
                                                                        
  CD80        rs4648091    0.025       rs4648090-rs4648091-rs4648095    0.049
              rs4648134    0.025       rs4648133-rs4648134-rs4648135    0.017
                                                                        
  FAS         rs4648134    0.032       \-\--                            \-\--
                                                                        
  ICAM1       rs4648134    0.032       rs4648133-rs4648134-rs4648135    0.050
                                                                        
  IRF1        rs1598859    0.032       rs1610152-rs1598859-rs3774956    0.040
              rs3774959    0.032       rs3821958-rs1020759-rs3774959    0.040
                                                                        
  VCAM1       rs7679591    0.011       rs230528-rs7679591-rs230526      0.040
              rs17032779   0.014       rs230521-rs230520-rs17032779     0.047
              rs4648018    0.014       rs4648016-rs4648018-rs230500     0.046
              rs4648069    0.014       rs4648055-rs4648068-rs4608069    0.049
              rs4648091    0.014       rs4648090-rs4648091-rs4648095    0.010
              rs4648134    0.014       rs4648133-rs4648134-rs4648135    0.050
              rs10489114   0.014       rs3774959-rs10489114-rs7377680   0.034
              rs4648015    0.014       rs230496-rs4648015-rs230498      0.041
              rs4648016    0.014       rs230498-rs4648016-rs4648018     0.046
              rs4648043    0.014       rs3774956-rs4648043-rs3821958    0.037

^a^Family-based association tests suggested SNP rs4648136 and haplotype rs4648134-rs4648135-rs4648136 associated with CD80, FAS and ICAM1 phenotypes.

###### 

Association analysis of *REL*using HapMap data^a^

  Phenotype   SNP          *p*-Value   Haplotype                         *p*-Value
  ----------- ------------ ----------- --------------------------------- -----------
  CD40        rs13422089   0.028       rs6545835-rs10208155-rs13422089   0.070
                                                                         
  IL15        rs842648     0.038       rs13422089-rs842648-rs13022703    0.050
                                                                         
  IRF1        rs842644     0.010       rs842644-rs6545836-rs10193964     0.050
                                                                         
  JUNB        rs6545835    0.047       rs6545835-rs10208155-rs13422089   0.050
              rs10208155   0.047       \-\--                             \-\--
              rs13422089   0.008       rs13422089-rs842648-rs13022703    0.048
              rs10185028   0.047       rs10185028-rs842647-rs842644      0.027
                                                                         
  SLC2A5      rs6545835    0.019       rs6545835-rs10208155-rs13422089   0.020
              rs10208155   0.019       rs6545835-rs10208155-rs13422089   0.020
              rs13422089   0.035       rs6545835-rs10208155-rs13422089   0.020
              rs10185028   0.019       rs10185028-rs842647-rs842644      0.004
              rs842644     0.047       rs10185028-rs842647-rs842644      0.004
              rs6545836    0.019       rs842647-rs842644-rs6545836       0.004
              rs10193964   0.019       rs842644-rs6545836-rs10193964     0.002
                                                                         
  VCAM1       rs842644     0.010       rs842644-rs6545836-rs10193964     0.048

^a^Family-based association tests did not suggest associations with the above phenotypes.

Association in unrelated individuals
------------------------------------

We examined associations between 15 expression phenotypes and genotypes at HapMap SNPs. Haplotype analyses indicated an overlap with the single SNP association results for *NFKB1*and *REL*(Table [1](#T1){ref-type="table"}). Among nine phenotypes associated with SNPs in *NFKB1*, six (BCL2A1, CD44, CD80, ICAM1, IRF1, and VCAM1) had suggestive haplotype associations. Among six phenotypes associated with *REL*SNPs, all six phenotypes had suggestive haplotype association (Table [1](#T1){ref-type="table"}). More detailed results are available upon request.

Discussion
==========

We utilized a variety of methods (association, linkage, and family-based association) in an attempt to understand the relationship between variation in NF-κB genes and expression levels of 15 proteins. We consider this to be an exploratory analysis of publicly available data with a limited sample size. We sought to reveal avenues for future study within the NF-κB pathway. As an assessment of these methods, we concluded that haplotype analysis combined with single-SNP analysis, family-based association tests, and linkage analysis has helped inform our understanding of the NF-κB pathway. Analyses revealed association and linkage between *NFKB1*and FAS, IRF1 expression phenotypes, and between *REL*and CD40 expression phenotype. FAS is a cell surface protein that belongs to the tumor necrosis factor (TNF) receptor family; signals through FAS are able to induce apoptosis. IRF1 is a member of the interferon regulatory transcription factor family, which regulates apoptosis and tumor-suppression. CD40 proteins also belong to TNF protein family, which is essential in mediating a broad variety of immune and inflammatory responses. Based upon our results, we concluded that variation in the *NFKB1*and *REL*genes may play a role in downstream regulation of FAS, IRF1, and CD40 expression.

There are several limitations to this study, including lack of adjustment for multiple tests on multiple loci and use of a small sample size; interpretation of tests on a sample of 14 warrants caution. No results were statistically significant after taking into account the multiple comparisons. Nonetheless, these exploratory analyses provide clues for further large scale studies.

Conclusion
==========

We make three general conclusions. First, single-SNP association testing was less conservative than haplotype and FBAT analysis, where haplotype analyses indicated association, results of single-SNP association testing were also significant; however, association found by single-SNP testing was not always revealed by haplotype analysis. Because this is not simulated data, we do not know whether the single-SNP results represent true or false positives. Second, because haplotype analysis requires two or more SNPs, for those genes with only one or very few SNPs, haplotype analysis might not be an appropriate analysis to perform. Third, FBAT analysis was relatively conservative compared to single-SNP and haplotype association analyses. FBAT found fewer SNPs and haplotypes with point-wise significance. In summary, we suggest that single-SNP and haplotype association analyses be used in first-stage analysis to generate a smaller set of candidate SNPs; FBAT and linkage analysis can then narrow down the list of potentially important loci.
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